Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
McKesson
Argus Health
Chubb
Cantor Fitzgerald
Harvard Business School
Express Scripts
QuintilesIMS
Johnson and Johnson
Julphar

Generated: August 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 201950

« Back to Dashboard
NDA 201950 describes RASAGILINE MESYLATE, which is a drug marketed by Watson Labs Inc, Apotex Inc, Orchid Hlthcare, and Mylan Pharms Inc, and is included in four NDAs. It is available from two suppliers. Additional details are available on the RASAGILINE MESYLATE profile page.

The generic ingredient in RASAGILINE MESYLATE is rasagiline mesylate. There are eighteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the rasagiline mesylate profile page.

Summary for NDA: 201950

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 0.5MG BASE
Approval Date:Sep 12, 2013TE:ABRLD:No
Regulatory Exclusivity Expiration:Jul 1, 2017
Regulatory Exclusivity Use:PATENT CHALLENGE

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 1MG BASE
Approval Date:Sep 12, 2013TE:ABRLD:No
Regulatory Exclusivity Expiration:Jul 1, 2017
Regulatory Exclusivity Use:PATENT CHALLENGE


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Boehringer Ingelheim
UBS
Citi
US Army
McKesson
Julphar
Chubb
Queensland Health
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot